Still Hungry on Mounjaro 5mg: What Patient Reviews Actually Show

The biggest misconception: 5mg should silence appetite completely

A lot of online reviews frame persistent hunger at 5mg as a sign that Mounjaro is not working. This is the misconception worth tackling first. Tirzepatide's dose schedule exists precisely because appetite suppression is dose-dependent: the medicine slows gastric emptying, increases satiety signalling through both GIP and GLP-1 receptors, but those effects deepen as the dose climbs. The 5mg pen is a middle rung on a ladder that runs from 2.5mg to 15mg.

Trial evidence from the SURMOUNT-1 study, published in the New England Journal of Medicine, recorded average weight reductions of around 20–21% at 15mg over 72 weeks, a figure reached after the full titration, not at the start. Participants who remained at lower doses did not achieve the same results. That tells you something: the dose matters, and 5mg is rarely where the full story ends.

If you're reading reviews from people who felt nothing at 5mg and then felt markedly different at 7.5mg or 10mg, that pattern is consistent with how the medicine is designed to work. It's also why your prescriber's timeline, not a forum thread, should anchor your expectations.

What actually drives hunger on 5mg, factors most reviews leave out

Persistent hunger at 5mg is not always about the dose alone. A question our prescribers hear most weeks is whether the injection day matters, and it does, somewhat. Tirzepatide peaks in the bloodstream a day or two after injection, so hunger is often mildest around days two and three, then edges back as the week goes on. This is normal pharmacokinetics, not the medicine wearing out.

Meal composition plays a bigger role than reviews tend to acknowledge. High-protein, high-fibre meals sustain the medicine's appetite-dampening effect; ultra-processed foods, which digest quickly, can restart hunger signals faster. Sleep disruption elevates ghrelin (the hunger hormone) regardless of medication. Stress does the same. None of this shows up in a star rating.

The NHS guidance on tirzepatide notes that it should be used alongside a reduced-calorie diet and increased physical activity, the medicine supports those changes, it doesn't replace them. If late-week hunger is significant and affecting how you eat, that's worth raising directly with your prescriber rather than interpreting reviews as evidence the dose should change.

How 5mg reviews compare with experiences at other doses

Patient accounts collected across forums, clinics and review platforms do show a consistent pattern: if you were still hungry on the 2.5mg starting dose, 5mg typically suppresses appetite more noticeably, and most people report the clearest effect somewhere between 7.5mg and 15mg. That gradient is exactly what structured reviews of the 5mg pen tend to confirm when you look past individual outliers.

Some people do experience strong appetite suppression at 5mg. Others feel almost nothing until 10mg or above. The range reflects genuine individual variation in receptor sensitivity, metabolic rate, and how long each person has spent at the current dose. Spending fewer than four weeks at a dose before drawing conclusions is one of the most common reasons people misread their own results.

For context on what changes at the next level, the experiences reported at 15mg tend to be markedly different from 5mg accounts, not because the medicine suddenly works, but because the cumulative titration has had time to take effect. If you're still on 5mg and feeling discouraged, comparing your experience to peak-dose reviews sets an unrealistic baseline.

Cost can be a factor too: some people are reluctant to move up because higher doses cost more privately. The price context around Mounjaro in the UK changed significantly from September 2025, and it's worth having an honest conversation with your prescriber about the full picture rather than staying at a lower dose purely for cost reasons.

What to do if you're still hungry at 5mg

First, note how long you've been at 5mg. If it's been less than four weeks, the guidance from NICE's appraisal of tirzepatide (TA1026) reflects that titration steps are typically four weeks apart, for tolerability as much as efficacy. Impatience is understandable; moving faster is a clinical decision, not one to take from a review thread.

Second, track your hunger with some structure. Note when it peaks during the week, what you ate beforehand, how you slept. That information is genuinely useful to a prescriber assessing whether your dose needs reviewing, whether your timing should shift, or whether something in your routine is working against the medicine.

Third, look at the reasons behind persistent hunger at 5mg in more depth, there's more clinical detail there on what the research says about appetite variability at this dose. And if you haven't yet started treatment or are considering switching providers, the free consultation at nume is reviewed the same day by a real prescriber, not automated software. That review is the right place to raise exactly these concerns.